Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.33 |
| ▸ | SLC9A1 | P19634 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4404245 | 0.98 | ALDH1A1 (0.41) | ALDH1A1LMNATSHR | |
| SCHEMBL4409185 | 0.92 | ALDH1A1 (0.42) | ALDH1A1LMNA | |
| SCHEMBL4414808 | 0.87 | SLC9A1 (0.42) | ALDH1A1SLC9A1 | |
| SCHEMBL4408311 | 0.87 | MEN1 (0.40) | LMNASLC9A1 | |
| SCHEMBL4407183 | 0.87 | SLC9A1 (0.42) | ALDH1A1SLC9A1 | |
| SCHEMBL4409237 | 0.87 | SLC9A1 (0.42) | ALDH1A1SLC9A1 | |
| SCHEMBL4409040 | 0.87 | CYP1A2 (0.39) | ALDH1A1LMNATSHRSLC9A1 | |
| SCHEMBL4405575 | 0.85 | SLC9A1 (0.41) | ALDH1A1LMNASLC9A1 | |
| SCHEMBL4414852 | 0.85 | KMT2A (0.41) | ALDH1A1LMNASLC9A1 | |
| SCHEMBL4407820 | 0.85 | CYP1A2 (0.40) | ALDH1A1LMNASLC9A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1859782-B1 | Composition for coloring and/or lightening human hair comprising tetrazoles | HENKEL AG & CO KGAA (DE) | 2009-12-30 | — | — | EP | disclosed |
| EP-1859782-A1 | Composition for coloring and/or lightening human hair comprising tetrazoles | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-11-28 | — | — | EP | disclosed |